Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Plast Reconstr Surg Glob Open ; 3(6): e425, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26180726

RESUMO

Keloids and hypertrophic scars represent excessive wound healing involving high production of collagen by skin fibroblasts. This review focuses on the role of high-mobility group box protein-1 (HMGB-1), matrix metalloproteinases (MMPs), and vitamin D in these conditions. Although the role of HMGB-1 in keloids and hypertrophic scars is unclear, the effect of HMGB-1 on fibroblasts suggests a profibrotic role and a potential contribution to excessive scarring. MMPs contribute extensively to wound healing and characteristically degrade the extracellular matrix. MMP-1 is decreased in keloids and hypertrophic scars. However, other MMPs, including MMP-2, have been found to be increased and are thought to possibly contribute to keloid expansion through peripheral extracellular matrix catabolism. Many novel therapeutic approaches to keloids and hypertrophic scars target MMPs and aim to increase their levels and catabolic activity. The higher prevalence of keloids in darker skin types may partially be due to a tendency for lower vitamin D levels. The physiologically active form of vitamin D, 1,25(OH)2D3, inhibits the proliferation of keloid fibroblasts, and correlations between vitamin D receptor polymorphisms, such as the TaqI CC genotype, and keloid formation have been reported. Additionally, vitamin D may exert an antifibrotic effect partially mediated by MMPs. Here, we critically discuss whether keloid and hypertrophic scar formation could be predicted based on vitamin D status and vitamin D receptor polymorphisms. Specifically, the findings identified HMGB-1, MMPs, and vitamin D as potential avenues for further clinical investigation and potentially novel therapeutic approaches to prevent the development of keloids and hypertrophic scars.

2.
Ann Plast Surg ; 49(5): 545-9, 2002 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12439025

RESUMO

The pathological entity of the buried penis occurs most commonly in children and is usually managed by urologists. Its presentation in the adult population may invoke plastic surgery expertise. The pathophysiology of buried penis in the adult is entirely distinct from that in children, and management principles may be complicated. Many plastic surgeons are unaware of the entity, even though they may be called to assist urology specialists in the management of complications in an adult patient. Not surprisingly, precious little information is available in the plastic surgical literature to provide management guidelines for this condition. This report highlights evaluation and management principles in an unusual case of adult (acquired, cicatricial) buried penis, and helps define the role of the plastic surgeon in such cases.


Assuntos
Tecido Adiposo , Cicatriz/complicações , Doenças do Pênis/etiologia , Doenças do Pênis/cirurgia , Procedimentos Cirúrgicos Urológicos Masculinos , Tecido Adiposo/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA